| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |